Inhibikase Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.3M | 3.3M | 1.62 |
| 2025-06-30 | $6.3M | 3.2M | 1.95 |
| 2025-03-31 | $6.2M | 2.8M | 2.19 |
| 2024-12-31 | $9.2M | 2.8M | 3.25 |
| 2024-09-30 | $22k | 17k | 1.30 |
| 2024-06-30 | $20k | 17k | 1.21 |
| 2024-03-31 | $36k | 17k | 2.16 |
| 2023-12-31 | $104k | 82k | 1.27 |
| 2023-09-30 | $122k | 87k | 1.39 |
| 2023-06-30 | $319k | 88k | 3.61 |